◆ 会议时间：2023年2月7日至10日
◆ 会议地点：英国 曼彻斯特

◆ 会议简介：

2023年第16届欧洲血友病及相关疾病协会(EAHAD)年会将于2023年2月7日至10日在英国曼彻斯特举行。大会组委会诚挚地邀请全球同事与朋友们参加这一传统的、十分独特的活动。EAHAD的目标是通过促进教育、支持研究和促进多学科方法来改善对遗传性或后天性出血性疾病患者的护理。一年一度的EAHAD大会是一个特别的机会，可以进一步增长我们的知识，更好地了解最新的科学进展，展示我们的最新发现，并积极与这一领域的医生、护士、物理治疗师和其他专家进行互动。上届会议总注册参会人数：3100名。

欧洲血友病和相关疾病协会（EAHAD）成立于2007年，是一个由致力于为患有血友病和其他出血性疾病的患者提供护理的医疗保健专业人士组成的多学科医学协会，成员包括血液学家、内科医生、儿科医生、护士、物理治疗师、实验室科学家和研究人员等。EAHAD的目标是为医学界相关人士和公众提供教育，宣促进科学研究，确保为患者提供最高质量的临床护理。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）

16th Annual Congress of The European Association for Haemophilia and Allied Disorders (EAHAD 2023)
Date: 7 – 10 February 2023
Location: Manchester, England

摘要征集：

Abstract Submission Deadline: End October 2022
Notifications to Submitters: End-November 2022
Abstracts received after the deadline will not be accepted!

点此提交摘要>>>Submit Abstract>>>

Abstracts can only be submitted online via the abstract submission form.

Abstracts sent by post or email will not be accepted. No exceptions will be made.

• Abstracts can be saved in “Draft” status to be re-edited and modified until the submission deadline: (End October 2022). Therefore, the submitter will be required to create a user account.
• Abstracts fulfilling all criteria can be saved in “Final submission” status. Only abstracts in “Final submission” status will be regarded as successfully submitted and considered for the Congress. The submitted / draft abstracts cannot be edited after the submission deadline (End October 2022).
• Abstracts are accepted on a wide range of topics in haemophilia and bleeding disorders. The submitter has to select the right topic for the abstract on the submission form. Available topics are:
  • Haemophilia
    • Haemophilia – Laboratory aspects, diagnostics
    • Haemophilia – Preclinical
    • Haemophilia – Clinical
  • Von Willebrand Disease
    • Von Willebrand Disease – Laboratory aspects, diagnostics
    • Von Willebrand Disease – Preclinical
    • Von Willebrand Disease – Clinical
  • Other bleeding disorders
  • Physiotherapy
  • Nursing
  • Psycho-social aspects
• The abstract should be structured into the following sections:
  • A title which clearly indicates the nature of the investigation.
  • Introduction should contain 1-2 sentences that clearly indicate the scientific question of the study and its clinical (or other) importance.
  • Methods should contain sufficient information to be able to understand the experimental design, the analytical techniques and the statistics used in the study.
  • Results should contain objective data to answer the scientific question(s).
  • Discussions / Conclusions should provide only conclusions of the study directly supported by the results, along with implications for clinical practice, avoiding speculation and overgeneralization.
  • No tables or figures are allowed in the abstract.
• Conflict of interest: It is the intent of EAHAD 2023 to provide high-quality sessions focused on educational content that is free from commercial influence or bias. Thus, the submitting author of an abstract is requested to declare any potential conflicts of interest for all authors during abstract submission.
• Abbreviations should be indicated in parentheses following their first mention in the text. Trade names cannot be mentioned in the title. However, trade names in brackets will be accepted in the body of the text.
• The submission of an abstract constitutes a formal commitment by the submitting (presenting) author to present the abstract (if accepted) in the session and the time assigned by the Programme Committee. Registration fees will not be waived.
• The presenting author of the abstract must be registered at the conference within 14 days of confirmation of abstract acceptance (the author will benefit from the early bird registration fee).
• Please ensure your abstract does not contain spelling, grammar, or scientific mistakes, as it will be reproduced exactly as submitted. Linguistic accuracy is your responsibility. No proofreading will be done. No changes can be made to the abstract after the submission deadline.
• Only original abstracts will be accepted and considered for the review.

Dear Colleagues and Friends,

After two years of online only meetings, I am delighted to inform you that the 16th Annual Congress of the European Association for Haemophilia and Allied Disorders, EAHAD 2023, will be a face-to-face meeting, which will take place in Manchester in the UK, from 8-10 February 2023.

On behalf of the EAHAD 2023 Organising Committee, I have the honour and great pleasure to invite you to this exciting event.

The objectives of EAHAD are to promote education, support research and improve the clinical care and lives of patients with inherited or acquired bleeding disorders. The annual Congress provides an opportunity to increase your knowledge, and better understand the most recent scientific advances, while also allowing you to present your latest findings and interact with physicians, nurses, physiotherapists, psychosocial professionals and all other caregivers involved in our field.

The venue for the Congress will be the Manchester Central Convention Complex, formerly the Manchester Central railway station. It is centrally located between the Bridgewater Hall and the Science and Industry Museum, and within walking distance of most hotels. Manchester International Airport, located 14km south of the city, has flights to 199 destinations.

We are looking forward to welcoming you to Manchester for what we are sure will be a memorable scientific experience!

Professor Mike Makris

EAHAD 2023 Congress President.

注册费：

THE BELOW REGISTRATION FEES APPLY FOR BOTH F2F AND VIRTUAL ONLY ATTENDANCE
THE BELOW FEES DO NOT INCLUDE APPLICABLE VAT

• Congress Pass (F2F)
  • Access to Sessions & Poster area
  • Congress documents, including badge and congress bag
  • Coffee breaks and lunches on Wednesday 8 February 2023, Thursday 9 February 2023, Friday 10 February 2023
  • Welcome Reception on Wednesday 8 February 2023
  • Satellite Symposia*
  • Multidisciplinary education session on Wednesday 8 February 2023
  • Access to the virtual platform
  • Applicable VAT is in addition to the featured rates
• Virtual Pass
  • Access to the virtual platform
  • Applicable VAT is in addition to the featured rates

*Please note that access to the Satellite Symposia is governed by their respective companies’ rules and regulations, over which EAHAD does not have control. Access restrictions to certain categories may apply based on the companies’ internal requirements.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。